Human Epididymis Protein 4 (HE4) mRNA as a Prognostic Marker in Ovarian Tumors in Relation to RMI and CA125

International Journal of Cancer Research - Pakistan
doi 10.3923/ijcr.2015.175.185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Science Alert

Related search

Biomarkers and Algorithms for Diagnosis of Ovarian Cancer: CA125, HE4, RMI and ROMA, a Review

Journal of Ovarian Research
GynecologyOncologyObstetrics
2019English

Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses

Asian Pacific Journal of Cancer Prevention
2019English

Use of a Symptom Index, CA125, and HE4 to Predict Ovarian Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2010English

Human Epididymis Protein-4 Gene Expression as a Biomarker in Patients With Ovarian Cancer in Iran

Open Journal of Clinical Diagnostics
2017English

Serum Human Epididymis Protein 4 (HE4) in the Differential Diagnosis of Peritoneal Tuberculosis: A Report of Two Cases

Balkan Medical Journal
Medicine
2014English

Immunohistochemical Expression of Human Epididymis 4 in Ovarian Malignancy

International Journal of Research in Medical Sciences
2019English

The Use of HE4, CA125 and CA72-4 Biomarkers for Differential Diagnosis Between Ovarian Endometrioma and Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Sialyl Tn as a Prognostic Marker in Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1992English

Identification of Human Epididymis Protein-4 as a Fibroblast-Derived Mediator of Fibrosis

Nature Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy